Skip to content

Ketamine: all studies

Page 370 of 449: studies 3,691 to 3,700 of 4,483, newest first. Back to the ketamine overview

Research

Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice.

Clinical Psychopharmacology and Neuroscience November 30, 2025 Alessandro Serretti 2 citations

Depression is increasingly conceptualized as a disorder of impaired synaptic plasticity and excitation-inhibition imbalance within corticolimbic circuits. Two rapid-acting therapeutic classes, NMDA receptor modulators (ketamine, esketamine) and neuroactive-steroid GABA-A positive allosteric modulators (brexanolone, zuranolone), offer complementary approaches to restore circuit function....

DOI: 10.9758/cpn.25.1349 (opens in new tab) Full text (opens in new tab) Antidepressive agents Depression, postpartum Neurosteroids

The NMDA receptor subunit GluN2D is a potential target for rapid antidepressant action

Nature Communications November 26, 2025 Stefan Vestring, Maxime Veleanu, Marina Conde Perez et al.

Ketamine is the first glutamatergic agent in clinical use for major depression, but its primary target remains unclear. Further research is needed to develop more specific interventions with fewer side effects. Ketamine is a noncompetitive antagonist of the glutamatergic N-methyl-D-aspartate (NMDA) receptor. Here, we show that ketamine preferentially targets GluN2D-containing NMDA receptors on...

A Mesoscale Framework for Psychedelic Drug Action in the Human Brain

bioRxiv November 26, 2025 Rui Dai, Rodrigo Cofré, Christopher Timmermann et al. preprint

The mechanism of psychedelic drug action is a dynamic area of neuroscience, with two major lines of investigation: (1) laboratory studies at the molecular and cellular level, and (2) human neuroimaging studies of functional brain networks. Despite considerable progress, there remains insufficient understanding of the link between molecular/cellular substrates of psychedelics and the whole-brain...

The Impact of Preoperative Positive Suggestions on Dreaming With Intravenous Sedation: A Randomized Controlled, Blinded Trial

Anesthesia & Analgesia November 24, 2025 Donggeon Lee, Hayoung Lee, Cheol-Hyeong Lee et al.

BACKGROUND: Drug-induced dreams during intravenous sedation vary by pharmacological agent and influence patient experiences, yet the role of preoperative positive suggestions in modulating these dreams is unclear. This study aimed to investigate the impact of preoperative positive suggestions on drug-induced dream recall (DIDR) frequency, dream content, and subjective perceptions during...

DOI: 10.1213/ane.0000000000007818 (opens in new tab) Dream Double blinded Randomized controlled trial Blinded study +7

Neurophysiological biomarkers of treatment response in suicidal ideation: a systematic review.

Translational Psychiatry November 17, 2025 Noah Stapper, Lindsay L Benster, Sahit Menon et al. 1 citation

Suicidal ideation (SI) is associated with increased morbidity and is one of the main modifiable risk factors for suicide. While initial evidence indicates the efficacy of several treatments for SI, most treatments were not developed to specifically target SI and are often associated with side effects or high relapse rates. Limited understanding of the neurophysiological basis of SI has hindered...

DOI: 10.1038/s41398-025-03477-2 (opens in new tab) Full text (opens in new tab) Suicidal thoughts treatment Brain activity Psychiatric therapies

Novel approaches for drug development against chronic primary pain: A systematic review.

British Journal of Pharmacology November 14, 2025 Valéria Tékus, Éva Borbély, Andreas Goebel et al. 5 citations

Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients. Therefore, identifying novel therapeutic targets and determining new treatments is important. In the present...

DOI: 10.1111/bph.70228 (opens in new tab) Full text (opens in new tab) Fibromyalgia Chronic pain management Novel pain treatments Pain mechanisms +1

Structural identification and metabolic profiling of the new psychoactive substance 2-fluoro-2-oxo-PCPr using NMR and LC-QTOF-MS.

Forensic Science International November 10, 2025 Seonghoon Yeon, Jisu Park, Byungseok Cho et al.

Fluorinated analogs of ketamine, such as 2-fluoro-deschloroketamine and its isomers, have recently emerged as dissociative anesthetics that act through multiple central nervous system pathways. As their prevalence continues to increase, metabolic studies are critical to confirm their use in suspected cases of abuse. 2-Fluoro-N-propylnordeschloroketamine (2-fluoro-2-oxo-PCPr), in which a propyl...

DOI: 10.1016/j.forsciint.2025.112716 (opens in new tab) Full text (opens in new tab) 2-fluoro-2-oxo-pcpr Giao-dft nmr calculations Interconverting rotamerization Metabolite profiling

PID-atom distributions for all subjects under different drugs and placebo effects using MMI definition.

OPAL (Open@LaTrobe) (La Trobe University) November 5, 2025 Alberto Liardi (22305679), Fernando E. Rosas (9595503), Robin L. Carhart-Harris (5923571) et al.

From left to right, results refer to LSD, ketamine, and psilocybin drugs. Panel rows represent (a) the raw values of PID atoms, (b) the NMI-normalised PID atoms, and (c) the NuMIT-normalised PID atoms. The dashed black lines are drawn at zero. (P-values calculated with a one-sample t-test against the zero-mean null hypothesis. *: ppp<0.001).

DOI: 10.1371/journal.pcbi.1013629.g004 (opens in new tab) Pid controller Placebo Pharmacology

Expansion and Regression in Oceanic Experience: A Model of Psychedelic Consciousness for Psychoanalysis

Psychoanalytic Dialogues November 2, 2025 Karen Peoples, Megan Rundel

In this paper, we take up the question of what happens from a psychoanalytic perspective when a patient engages in psychedelic-assisted therapy. While some writers have suggested that psychedelic agents promote regression to an earlier point in development, we argue that such states may be better understood as expanding the mind beyond ordinary consciousness. We assert that traditional models...

DOI: 10.1080/10481885.2025.2574574 (opens in new tab) Consciousness Regression analysis Psychoanalytic theory Linear regression +1

Looking Up at the Stars from the Middle of the Lake: Dare We Speak of Spirit? A Model of Psychedelic Consciousness for Psychoanalysis

Psychoanalytic Dialogues November 2, 2025 David Raniere 1 citation

This discussion extends psychoanalytic theory and practice to engage expanded states of consciousness elicited by psychedelic medicine. The author utilizes Peoples and Rundel’s clinical illustration involving ketamine-assisted psychoanalysis to propose the intra-collective as a transpersonal holding environment that encompasses and contains the intersubjective field, where highly organized,...

DOI: 10.1080/10481885.2025.2574584 (opens in new tab) Consciousness Stars The imaginary Psychoanalytic theory +1